Antibiotic Dosing in Patients With Acute Kidney Injury

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Intensive Care Medicine

• Publication date

  2016-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/0885066614555490PMID 25326429
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intensity of Renal Support in Critically Ill Patients with Acute Kidney Injury

  2018cited by this paper
• Longitudinal Hemodiafilter Performance in Modeled Continuous Renal Replacement Therapy

  2016cited by this paper
• Renal Replacement Therapy.

  2015cited by this paper
• Consequences of Renal Failure on Non-Renal Clearance of Drugs

  2014cited by this paper
• Variability of linezolid concentrations after standard dosing in critically ill patients: a prospective observational study

  2014cited by this paper
• Dosing errors in prescribed antibiotics for older persons with CKD: a retrospective time series analysis.

  2014cited by this paper
• Efficacy and Safety of Daptomycin in Patients with Renal Impairment: A Multicenter Retrospective Analysis

  2014cited by this paper
• Drug prescribing in kidney disease: can't we do better?

  2014cited by this paper
• Cefepime neurotoxicity in the intensive care unit: a cause of severe, underappreciated encephalopathy

  2013cited by this paper
• Pharmacokinetics of Meropenem in Critically Ill Patients With Severe Infections

  2013cited by this paper
• Continuous intravenous administration of vancomycin in medical intensive care unit patients.

  2013influential reference
• Association between renal replacement therapy in critically ill patients with severe acute kidney injury and mortality.

  2013cited by this paper
• Pharmacokinetics of Ertapenem in Critically Ill Patients Receiving Continuous Venovenous Hemodialysis or Hemodiafiltration

  2013cited by this paper
• Clinical outcomes with extended or continuous versus short-term intravenous infusion of carbapenems and piperacillin/tazobactam: a systematic review and meta-analysis.

  2013cited by this paper
• Optimal dosing of antibiotics in critically ill patients by using continuous/extended infusions: a systematic review and meta-analysis

  2013cited by this paper
• Drug absorption, distribution, metabolism and excretion considerations in critically ill adults

  2013cited by this paper
• A new regimen for continuous infusion of vancomycin during continuous renal replacement therapy.

  2013influential reference
• Surviving sepsis campaign : international guidelines for management of severe sepsis and septic shock

  2013cited by this paper
• Continuous infusion of vancomycin in septic patients receiving continuous renal replacement therapy.

  2013influential reference
• Milligrams per Liter Maintain Troughs between 15 and 20 Associated with Dosing Schedules That Vancomycin-Induced Nephrotoxicity Systematic Review and Meta-Analysis of

  2013cited by this paper
• Pro: Renal replacement trauma or Paracelsus 2.0.

  2013cited by this paper
• Medication dosing in critically ill patients with acute kidney injury treated with renal replacement therapy.

  2013cited by this paper
• Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012

  2013cited by this paper
• Fluid balance and urine volume are independent predictors of mortality in acute kidney injury

  2013cited by this paper
• The epidemiology of septic shock in French intensive care units: the prospective multicenter cohort EPISS study

  2013cited by this paper
• Gentamicin in Hemodialyzed Critical Care Patients: Early Dialysis after Administration of a High Dose Should Be Considered

  2012cited by this paper
• Adding to the armamentarium: antibiotic dosing in extended dialysis.

  2012cited by this paper
• Analysis of risk factors for adverse drug events in critically ill patients*

  2012influential reference
• Renal Replacement Therapy

  2012cited by this paper
• The Clinical Relevance of Plasma Protein Binding Changes

  2012cited by this paper
• Systematic Review and Meta-Analysis of Vancomycin-Induced Nephrotoxicity Associated with Dosing Schedules That Maintain Troughs between 15 and 20 Milligrams per Liter

  2012cited by this paper
• Pharmacokinetics and pharmacodynamics of piperacillin-tazobactam in 42 patients treated with concomitant CRRT.

  2012cited by this paper
• Introduction to drug pharmacokinetics in the critically ill patient.

  2012cited by this paper
• Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database.

  2012cited by this paper
• Multiple-dose pharmacokinetics of daptomycin during continuous venovenous haemodiafiltration.

  2012cited by this paper
• Simple approach to improving vancomycin dosing in intensive care: a standardised loading dose results in earlier therapeutic levels

  2012cited by this paper
• Subtherapeutic initial β-lactam concentrations in select critically ill patients: association between augmented renal clearance and low trough drug concentrations.

  2012cited by this paper
• Dosing Regimen Matters: the Importance of Early Intervention and Rapid Attainment of the Pharmacokinetic/Pharmacodynamic Target

  2012cited by this paper
• Relationship between Vancomycin Trough Concentrations and Nephrotoxicity: a Prospective Multicenter Trial

  2011cited by this paper
• Fluid balance, diuretic use, and mortality in acute kidney injury.

  2011cited by this paper
• Vancomycin levels are frequently subtherapeutic during continuous venovenous hemodialysis (CVVHD)

  2011cited by this paper
• Pharmacokinetics of a loading dose of amikacin in septic patients undergoing continuous renal replacement therapy.

  2011influential reference
• Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy

  2011cited by this paper
• Acute kidney injury reduces the hepatic metabolism of midazolam in critically ill patients

  2011cited by this paper
• Antibiotic dosing in critically ill patients with acute kidney injury

  2011cited by this paper
• Appropriate Antibiotic Dosage Levels in the Treatment of Severe Sepsis and Septic Shock

  2011cited by this paper
• Resistance to empiric antimicrobial treatment predicts outcome in severe sepsis associated with Gram-negative bacteremia.

  2011influential reference
• Plasma pharmacokinetics of daptomycin in critically ill patients with renal failure and undergoing CVVHD.

  2011cited by this paper
• Recommended b-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy

  2011influential reference
• Antibiotic dosing during sustained low-efficiency dialysis: Special considerations in adult critically ill patients*

  2011cited by this paper
• Daptomycin pharmacokinetics in critically ill patients receiving continuous venovenous hemodialysis

  2011cited by this paper
• Longitudinal Hemodiafilter Performance in Modeled Continuous Renal Replacement Therapy

  2011cited by this paper
• Sustained low efficiency dialysis allows rational renal replacement therapy, but does it allow rational drug dosing?

  2011cited by this paper
• Dosing of antibiotics in critically ill patients undergoing renal replacement therapy.

  2011cited by this paper
• Principles of Antibacterial Dosing in Continuous Renal Replacement Therapy

  2010cited by this paper
• Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury

  2010cited by this paper
• Using Population Pharmacokinetics To Determine Gentamicin Dosing during Extended Daily Diafiltration in Critically Ill Patients with Acute Kidney Injury

  2010cited by this paper
• Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America

  2010cited by this paper
• Prospective monitoring of cefepime in intensive care unit adult patients

  2010influential reference
• Inappropriate antibiotic therapy in Gram-negative sepsis increases hospital length of stay*

  2010cited by this paper
• Dosing of daptomycin in intensive care unit patients with acute kidney injury undergoing extended dialysis--a pharmacokinetic study.

  2010cited by this paper
• Predictors of acute kidney injury associated with intravenous colistin treatment.

  2010cited by this paper
• Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock

  2010cited by this paper
• Increasing vancomycin serum trough concentrations and incidence of nephrotoxicity.

  2010cited by this paper
• Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients.

  2009cited by this paper
• Delivered dose of renal replacement therapy and mortality in critically ill patients with acute kidney injury

  2009cited by this paper
• Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury.

  2009cited by this paper
• The effect of dialysis on the protein binding of drugs in the plasma of patients with acute renal failure.

  2009influential reference
• International study of the prevalence and outcomes of infection in intensive care units.

  2009cited by this paper
• Five-year outcomes of severe acute kidney injury requiring renal replacement therapy

  2009cited by this paper
• Nephrotoxicity associated with intravenous colistin (colistimethate sodium) treatment at a tertiary care medical center.

  2009cited by this paper
• Principles of antibacterial dosing in continuous renal replacement therapy

  2009cited by this paper
• Continuous-Infusion β-Lactam Antibiotics During Continuous Venovenous Hemofiltration for the Treatment of Resistant Gram-Negative Bacteria

  2009influential reference
• Intensity of continuous renal-replacement therapy in critically ill patients.

  2009cited by this paper
• Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America.

  2009cited by this paper
• Rational dosing of antimicrobial agents: pharmacokinetic and pharmacodynamic strategies.

  2009cited by this paper
• Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists.

  2009cited by this paper
• Challenges in Developing Evidence‐Based Drug Dosing Guidelines for Adults and Children Receiving Renal Replacement Therapy

  2009cited by this paper
• Antimicrobial Dosing Concepts and Recommendations for Critically Ill Adult Patients Receiving Continuous Renal Replacement Therapy or Intermittent Hemodialysis

  2009cited by this paper
• Clinical review: Drug metabolism and nonrenal clearance in acute kidney injury

  2008cited by this paper
• Five-year outcomes of severe acute kidney injury requiring renal replacement therapy.

  2008cited by this paper
• Piperacillin-Tazobactam for Pseudomonas aeruginosa Infection: Clinical Implications of an Extended-Infusion Dosing Strategy

  2008cited by this paper
• Intensity of renal support in critically ill patients with acute kidney injury.

  2008cited by this paper
• Influence of hemodialysis on gentamicin pharmacokinetics, removal during hemodialysis, and recommended dosing.

  2008cited by this paper
• The impact of antimicrobial-resistant, health care-associated infections on mortality in the United States.

  2008cited by this paper
• The research agenda of the National Institute of Allergy and Infectious Diseases for antimicrobial resistance.

  2008cited by this paper
• Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections.

  2008cited by this paper
• Larger Vancomycin Doses (at Least Four Grams per Day) Are Associated with an Increased Incidence of Nephrotoxicity

  2008cited by this paper
• Short- and long-term survival after acute kidney injury.

  2008cited by this paper
• Outcomes of bacteremia due to Pseudomonas aeruginosa with reduced susceptibility to piperacillin-tazobactam: implications on the appropriateness of the resistance breakpoint.

  2008cited by this paper
• A positive fluid balance is associated with a worse outcome in patients with acute renal failure

  2008cited by this paper
• Carbapenems: a potent class of antibiotics

  2008cited by this paper
• Cephalosporin-Induced Neurotoxicity: Clinical Manifestations, Potential Pathogenic Mechanisms, and the Role of Electroencephalographic Monitoring

  2008cited by this paper
• Pharmacokinetics of linezolid in bone tissue investigated by in vivo microdialysis

  2008cited by this paper
• Pharmacokinetics of meropenem during intermittent and continuous intravenous application in patients treated by continuous renal replacement therapy

  2008influential reference
• Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia.

  2008cited by this paper
• The incidence and prognostic significance of acute kidney injury.

  2007cited by this paper
• Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008

  2007cited by this paper
• Pharmacokinetic/pharmacodynamic analysis of vancomycin in ICU patients

  2007cited by this paper
• Elimination of daptomycin in a patient with acute renal failure undergoing extended daily dialysis.

  2007cited by this paper

• Individualized drug therapy and survival prediction in ICU patients with acute kidney injury: construction and validation of a nomogram

  2025cites this paper
• Kinetic estimated glomerular filtration rate and drug dosing in critically ill patients with acute kidney injury—A prospective observational study

  2025cites this paper
• Chronic lung diseases and kidney disease: pathophysiology and management

  2025cites this paper
• Comparison of Pharmacokinetic/Pharmacodynamic Parameters and Clinical Outcomes of Vancomycin Administered in Two Different Dosage Regimens in Patients with Acute Kidney Injury

  2025cites this paper
• Adequate posology of antimicrobial therapy in the septic critically ill in continuous veno-venous hemofiltration: a single centre prospective observational study.

  2025cites this paper
• The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024

  2025cites this paper
• The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024

  2025cites this paper
• Early Versus Late Antipseudomonal β-Lactam Antibiotic Dose Adjustment in Critically Ill Sepsis Patients With Acute Kidney Injury: A Prospective Observational Cohort Study

  2024cites this paper
• Kidney Replacement Therapy in the ICU

  2024cites this paper
• Treatment of Acute Kidney Injury: A Review of Current Approaches and Emerging Innovations

  2024cites this paper
• Ceftazidime-avibactam induced renal disorders: past and present

  2024cites this paper
• Vancomycin administration and AUC/MIC in patients with acute kidney injury on hemodialysis (HD): randomized clinical trial

  2024cites this paper
• Piperacillin‐tazobactam dosing in anuric acute kidney injury patients receiving continuous renal replacement therapy

  2023cites this paper
• Incidence of Antimicrobial-Associated Acute Kidney Injury in Children: A Structured Review

  2023cites this paper
• Caring for two in the ICU: Pharmacotherapy in the critically ill pregnant patient

  2023cites this paper
• Antimicrobial therapy in resource-limited settings with high antimicrobial resistance: a case-based approach.

  2022cites this paper
• The Serum Concentration of Vancomycin as a Diagnostic Predictor of Nephrotoxic Acute Kidney Injury in Critically Ill Patients

  2022cites this paper
• Pharmacokinetic and pharmacodynamic considerations of antibiotics and antifungals in liver transplantation recipients

  2022cites this paper
• Antimicrobial safety considerations in critically ill patients: part I: focused on acute kidney injury

  2022cites this paper
• Efficacy and safety of novel carbapenem–β-lactamase inhibitor combinations: Results from phase II and III trials

  2022cites this paper
• Antibiotic Therapy in the Critically Ill with Acute Renal Failure and Renal Replacement Therapy: A Narrative Review

  2022influential citation
• “CATCH” Study: Correct Antibiotic Therapy in Continuous Hemofiltration in the Critically Ill in Continuous Renal Replacement Therapy: A Prospective Observational Study

  2022cites this paper
• β-Lactam Dosing in Critical Patients: A Narrative Review of Optimal Efficacy and the Prevention of Resistance and Toxicity

  2022cites this paper
• Anti-infective Therapy in Sepsis and Septic Shock

  2022cites this paper
• CRRT prescription and delivery of dose

  2021cites this paper
• Optimising the timing of renal replacement therapy in acute kidney injury

  2021cites this paper
• The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020)

  2021cites this paper
• The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J‐SSCG 2020)

  2021cites this paper
• Conceptual model of adding antibiotics to dialysate fluid during renal replacement therapy

  2021cites this paper
• Drug Dosing Considerations in Critically Ill Patients Receiving Continuous Renal Replacement Therapy

  2020cites this paper
• Serum Concentration of Vancomycin Is a Diagnostic Predictor of Nephrotoxic Acute Kidney Injury in Septic Patients in Clinical and Surgical Wards

  2020cites this paper
• Drug Dosing in Renal Failure in ICU

  2020cites this paper
• Harmonizing antibiotic regimens with renal replacement therapy

  2020cites this paper
• The role of PK/PD–based strategies to preserve new molecules against multi-drug resistant gram-negative strains

  2020cites this paper
• Vancomycin for Dialytic Therapy in Critically Ill Patients: Analysis of Its Reduction and the Factors Associated with Subtherapeutic Concentrations

  2020cites this paper
• Optimal levofloxacin dosing regimens in critically ill patients with acute kidney injury receiving continuous renal replacement therapy.

  2020cites this paper
• Frequency of Exposure of Nephrotoxic Drugs and Drug-Induced Acute Kidney Injury in Pediatric Intensive Care Unit: A Retrospective Review From a Tertiary Care Centre in Pakistan

  2020cites this paper
• Antibacterial therapy of sepsis in extracorporeal detoxication: current problems and ways to solve them

  2020cites this paper
• Dosing of antibiotics in patients with sepsis, including those undergoing renal replacement therapy

  2019cites this paper
• Dose in continuous renal replacement therapy.

  2019cites this paper
• [Ajuste de fármacos y nutrición en terapias de reemplazo renal continuo].

  2019cites this paper
• Continuous Renal Replacement Therapy: Who, When, Why, and How

  2019cites this paper
• Principles of Antimicrobial Prescription in Intensive Care Unit Patients With Acute Kidney Injury

  2019cites this paper
• Vancomycin dosing, monitoring and toxicity: Critical review of the clinical practice

  2019cites this paper
• Spotlights on Antibiotic-induced Acute Kidney Injury: the Evidence to Date.

  2019cites this paper
• Vancomycin Removal During High-Volume Peritoneal Dialysis in Acute Kidney Injury Patients

  2019cites this paper
• Principles of Pharmacodynamics and Pharmacokinetics of Drugs Used in Extracorporeal Therapies

  2019cites this paper
• Doripenem dosing regimens in Asian critically ill patients with continuous renal replacement therapy.

  2019cites this paper
• Basic Principles of Antibiotics Dosing in Patients with Sepsis and Acute Kidney Damage Treated with Continuous Venovenous Hemodiafiltration

  2019cites this paper
• Cefepime dosing regimens in critically ill patients receiving continuous renal replacement therapy: a Monte Carlo simulation study

  2018cites this paper
• Maximally effective dosing regimens of meropenem in patients with septic shock

  2018cites this paper
• Renal Dosing of Antibiotics: Are We Jumping the Gun?

  2018cites this paper
• Acetaminophen clearance during ex vivo continuous renal replacement therapies

  2018cites this paper
• Vancomycin Removal During High-Volume Peritoneal Dialysis in Acute Kidney Injury Patients: A Prospective Cohort Clinical Study

  2018cites this paper
• Effect and Safety of Meropenem–Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial

  2018cites this paper
• Drug management in acute kidney disease – Report of the Acute Disease Quality Initiative XVI meeting

  2017cites this paper
• Prevention and Therapy of Acute Kidney Injury in the Developing World

  2017cites this paper
• Skin and soft-tissue infections: Factors associated with mortality and re-admissions.

  2017cites this paper
• Antibiotic Dosing in Continuous Renal Replacement Therapy.

  2017cites this paper
• Drug-associated acute kidney injury: who’s at risk?

  2016cites this paper
• Use of Monte Carlo Simulations to Determine Optimal Carbapenem Dosing in Critically Ill Patients Receiving Prolonged Intermittent Renal Replacement Therapy

  2016cites this paper
• Precision Continuous Renal Replacement Therapy and Solute Control

  2016cites this paper
• ATS Core Curriculum 2016: Part II. Adult Critical Care Medicine.

  2016cites this paper
• Antimicrobial Doses in Continuous Renal Replacement Therapy: A Comparison of Dosing Strategies

  2016cites this paper
• Pharmacokinetics and pharmacodynamics of antibiotics in critically ill acute kidney injury patients

  2016influential citation
• Survey of pharmacists’ antibiotic dosing recommendations for sustained low-efficiency dialysis

  2016cites this paper
• We Underdose Antibiotics in Patients on CRRT

  2016cites this paper
• Antibiotic Dosing in Critically Ill Patients Undergoing Renal Replacement Therapy.

  2015cites this paper
• World Journal of Nephrology

  year unknowncites this paper